デフォルト表紙
市場調査レポート
商品コード
1762405

大動脈腸骨動脈閉塞性疾患治療市場、規模、シェア、産業分析レポート:デバイスタイプ別、手技別、最終用途別、地域別、2025年~2034年の市場予測

Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034


出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
大動脈腸骨動脈閉塞性疾患治療市場、規模、シェア、産業分析レポート:デバイスタイプ別、手技別、最終用途別、地域別、2025年~2034年の市場予測
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、大動脈腸骨動脈閉塞性疾患治療市場規模は2034年までに35億6,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

大動脈腸骨動脈閉塞性疾患治療市場は、一般的にアテローム性動脈硬化症によって引き起こされる、大動脈と腸骨動脈で発生する動脈閉塞の内科的および外科的管理に対処します。糖尿病、高血圧、肥満などの慢性疾患の増加により、血管内治療と開腹手術の両方に対する臨床需要が高まっています。血管内治療、特に血管形成術とステント留置術は、合併症発生率の低さ、入院期間の短縮、患者の転帰の改善により、好ましい治療アプローチとなっています。

市場の成長を支えているのは、薬剤溶出ステント、生体吸収性スキャフォールド、画像誘導ナビゲーションシステムなど、精度と長期的有効性を高める機器技術の進歩です。業界各社は、複雑な病変や多層閉塞を治療するためのハイブリッド血行再建術に注力しており、治療最適化のための新たな道を切り開いています。また、低侵襲治療が大量に行われる外来血管治療センターへの動向も高まっています。早期発見,リスク層別化,生活習慣改善プログラムが重視されるようになり,統合ケアモデルの重要性が高まっています。

画像診断、人工知能、血管ロボット工学の融合は治療のパラダイムを徐々に変えつつあり、より個別化されたデータ主導の治療への道を開いています。臨床試験と市販後調査への投資は、機器の安全性、耐久性、性能の指標を提供し続けています。十分な治療を受けていない集団における次世代治療へのアクセスの拡大や、高リスク患者の転帰を改善するための治療アルゴリズムの改良にこそ、ビジネスチャンスがあります。この市場は、手技の効率性、長期開存性、患者のQOLを重視した、より技術的に有効でアウトカムに焦点を当てたエコシステムへと着実に進化しています。

大動脈閉塞性疾患治療市場レポート・ハイライト

デバイスの種類別では、2024年に血管内治療デバイス分野が最大のシェアを獲得したが、これは主に大動脈-腸骨閉塞性疾患の管理において低侵襲手術への嗜好が高まっていることが背景にあります。

エンドユースに基づくと、2024年には、病院セグメントが最大のシェアを占めました。これは、集学的チーム、高度な画像診断、外科的バックアップを必要とする高リスク症例を管理する能力によって後押しされました。

2024年、北米の大動脈腸骨動脈閉塞性疾患治療市場が最大のシェアを占めたのは、先進的な血管内治療法の普及、強力な償還制度、早期診断の実践によるものでした。

アジア太平洋大動脈腸骨動脈閉塞性疾患治療市場は、ヘルスケアへのアクセス向上、医療インフラの拡大、血管疾患に対する意識の高まりにより、予測期間中に最も高いCAGRを記録すると予測されています。

世界の主要企業としては、Abbott;BD;Bentley InnoMed;Biotronik SE &Co KG;Boston Scientific Corporation;Cook;Getinge AB;iVascular;Medtronic;Scitech Medical;Terumo Corporation;W. L. Gore &Associates, Inc.

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の大動脈腸骨動脈閉塞性疾患治療市場の洞察

  • 市場スナップショット
  • 大動脈腸骨動脈閉塞性疾患治療市場力学
    • 促進要因と機会
      • 末梢動脈疾患(PAD)の有病率の上昇
      • 高齢化人口の増加
    • 抑制要因と課題
      • 高度な治療の高額な費用
  • PESTEL分析
  • 大動脈腸骨動脈閉塞性疾患治療市場の動向
  • バリューチェーン分析

第5章 世界の大動脈腸骨動脈閉塞性疾患治療市場:デバイスタイプ別

  • 主な調査結果
  • イントロダクション
  • 血管内デバイス
  • 外科用機器

第6章 世界の大動脈腸骨動脈閉塞性疾患治療市場:手技別

  • 主な調査結果
  • イントロダクション
  • 血管内手術
  • ハイブリッド手術
  • 開腹手術

第7章 世界の大動脈腸骨動脈閉塞性疾患治療市場:最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 外来施設
  • その他

第8章 世界の大動脈腸骨動脈閉塞性疾患治療市場:地域別

  • 主な調査結果
  • イントロダクション
    • 大動脈腸骨動脈閉塞性疾患治療市場評価:地域別、2020年~2034年
  • 北米
    • 北米:デバイスタイプ別、2020~2034年
    • 北米:手技別、2020~2034年
    • 北米:最終用途別、2020~2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州:デバイスタイプ別、2020~2034年
    • 欧州:手技別、2020~2034年
    • 欧州:最終用途別、2020~2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域:デバイスタイプ別、2020年~2034年
    • アジア太平洋地域:手技別、2020~2034年
    • アジア太平洋地域:最終用途別、2020~2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ:デバイスタイプ別、2020年~2034年
    • 中東・アフリカ:手技別、2020~2034年
    • 中東・アフリカ:最終用途別、2020~2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ:デバイスタイプ別、2020年~2034年
    • ラテンアメリカ:手技別、2020~2034年
    • ラテンアメリカ:最終用途別、2020~2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Abbott
  • BD.
  • Bentley InnoMed
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Cook
  • Getinge AB
  • iVascular
  • Medtronic
  • Scitech Medical
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
図表

List of Tables:

  • Table 1 Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 2 Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 3 Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 5 North America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 6 North America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 9 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 12 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 15 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 17 UK: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 18 UK: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 20 France: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 21 France: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 24 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 27 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 30 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 36 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 44 China: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 45 China: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 47 India: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 48 India: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 54 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 60 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 63 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 75 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 78 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 81 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 87 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 90 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 93 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 96 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Aorto-Iliac Occlusive Disease Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Device Type
  • Figure 7. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Procedure
  • Figure 9. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2024 & 2034 (USD Billion)
目次
Product Code: PM5750

The aorto-iliac occlusive disease treatment market size is expected to reach USD 3.56 billion by 2034, according to a new study by Polaris Market Research. The report "Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The aorto-iliac occlusive disease treatment market addresses the medical and surgical management of arterial blockages occurring in the aorta and iliac arteries, typically caused by atherosclerosis. The increasing prevalence of chronic conditions such as diabetes, hypertension, and obesity has intensified clinical demand for both endovascular and open surgical interventions. Endovascular procedures, particularly angioplasty and stenting, have become the preferred therapeutic approach due to their lower complication rates, reduced hospital stays, and improved patient outcomes.

Market growth is supported by advancements in device technologies, including drug-eluting stents, bioresorbable scaffolds, and image-guided navigation systems, which enhance precision and long-term efficacy. Industry players are focusing on hybrid revascularization techniques to treat complex lesions and multilevel occlusions, creating new avenues for treatment optimization. There is also a rising trend toward outpatient vascular care centers, where minimally invasive interventions are being performed in high volumes. Increasing emphasis on early detection, risk stratification, and lifestyle modification programs has elevated the importance of integrated care models.

The convergence of diagnostic imaging, artificial intelligence, and vascular robotics is gradually transforming the treatment paradigm, paving the way for more personalized, data-driven interventions. Investments in clinical trials and post-market surveillance studies continue to inform device safety, durability, and performance metrics. Opportunities lie in expanding access to next-generation therapies in underserved populations and refining treatment algorithms to improve outcomes in high-risk patients. The market is steadily evolving into a more technologically enabled, outcome-focused ecosystem that emphasizes procedural efficiency, long-term patency, and patient quality of life.

Aorto-Iliac Occlusive Disease Treatment Market Report Highlights

By device type, in 2024, the endovascular devices segment captured the largest share, primarily driven by the increasing preference for minimally invasive surgery in managing aorto-iliac occlusive disease.

Based on end use, in 2024, the hospitals segment accounted for the largest share, fueled by their capacity to manage high-risk cases requiring multidisciplinary teams, advanced imaging, and surgical backup.

In 2024, the North America aorto-iliac occlusive disease treatment market accounted for the largest share due to the widespread use of advanced endovascular procedures, strong reimbursement frameworks, and early diagnosis practices.

The Asia Pacific aorto-iliac occlusive disease treatment market is projected to register the highest CAGR during the forecast period due to rising healthcare access, expanding medical infrastructure, and increasing awareness of vascular conditions.

A few global key players include Abbott; BD.; Bentley InnoMed; Biotronik SE & Co KG; Boston Scientific Corporation; Cook; Getinge AB; iVascular; Medtronic; Scitech Medical; Terumo Corporation; W. L. Gore & Associates, Inc.; and ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Polaris Market Research has segmented the aorto-iliac occlusive disease treatment market on the basis of device type, procedure, end use, and region:

By Device Type Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Devices

Balloon Angioplasty Devices

Atherectomy Systems

Stents

Surgical Devices

By Procedure Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Procedures

Hybrid Procedures

Open Surgical Procedures

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Outpatient Facilities

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Aorto-Iliac Occlusive Disease Treatment Market Insights

  • 4.1. Aorto-Iliac Occlusive Disease Treatment Market - Market Snapshot
  • 4.2. Aorto-Iliac Occlusive Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Peripheral Arterial Disease (PAD)
      • 4.2.1.2. Growing Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Advanced Treatments
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Aorto-Iliac Occlusive Disease Treatment Market Trends
  • 4.6. Value Chain Analysis

5. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • 5.3. Endovascular Devices
    • 5.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Devices, by Region, 2020-2034 (USD Billion)
  • 5.4. Surgical Devices
    • 5.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Surgical Devices, by Region, 2020-2034 (USD Billion)

6. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • 6.3. Endovascular Procedures
    • 6.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Procedures, by Region, 2020-2034 (USD Billion)
  • 6.4. Hybrid Procedures
    • 6.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hybrid Procedures, by Region, 2020-2034 (USD Billion)
  • 6.5. Open Surgical Procedures
    • 6.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Open Surgical Procedures, by Region, 2020-2034 (USD Billion)

7. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Outpatient Facilities
    • 7.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Outpatient Facilities, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Aorto-Iliac Occlusive Disease Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Aorto-Iliac Occlusive Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Aorto-Iliac Occlusive Disease Treatment Market - North America
    • 8.3.1. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.3.3. North America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Aorto-Iliac Occlusive Disease Treatment Market - U.S.
      • 8.3.4.1. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Aorto-Iliac Occlusive Disease Treatment Market - Canada
      • 8.3.5.1. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Aorto-Iliac Occlusive Disease Treatment Market - Europe
    • 8.4.1. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Aorto-Iliac Occlusive Disease Treatment Market - UK
      • 8.4.4.1. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Aorto-Iliac Occlusive Disease Treatment Market - France
      • 8.4.5.1. France: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Aorto-Iliac Occlusive Disease Treatment Market - Germany
      • 8.4.6.1. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Aorto-Iliac Occlusive Disease Treatment Market - Italy
      • 8.4.7.1. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Aorto-Iliac Occlusive Disease Treatment Market - Spain
      • 8.4.8.1. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Aorto-Iliac Occlusive Disease Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Aorto-Iliac Occlusive Disease Treatment Market - Russia
      • 8.4.10.1. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Aorto-Iliac Occlusive Disease Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Aorto-Iliac Occlusive Disease Treatment Market - China
      • 8.5.4.1. China: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Aorto-Iliac Occlusive Disease Treatment Market - India
      • 8.5.5.1. India: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Aorto-Iliac Occlusive Disease Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Aorto-Iliac Occlusive Disease Treatment Market - Japan
      • 8.5.7.1. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Aorto-Iliac Occlusive Disease Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Aorto-Iliac Occlusive Disease Treatment Market - South Korea
      • 8.5.9.1. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Aorto-Iliac Occlusive Disease Treatment Market - Australia
      • 8.5.10.1. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Aorto-Iliac Occlusive Disease Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Aorto-Iliac Occlusive Disease Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Aorto-Iliac Occlusive Disease Treatment Market - UAE
      • 8.6.5.1. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Aorto-Iliac Occlusive Disease Treatment Market - Israel
      • 8.6.6.1. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Aorto-Iliac Occlusive Disease Treatment Market - South Africa
      • 8.6.7.1. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Aorto-Iliac Occlusive Disease Treatment Market - Latin America
    • 8.7.1. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Aorto-Iliac Occlusive Disease Treatment Market - Mexico
      • 8.7.4.1. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Aorto-Iliac Occlusive Disease Treatment Market - Brazil
      • 8.7.5.1. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Aorto-Iliac Occlusive Disease Treatment Market - Argentina
      • 8.7.6.1. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BD.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bentley InnoMed
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Biotronik SE & Co KG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Boston Scientific Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Cook
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Getinge AB
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. iVascular
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Medtronic
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Scitech Medical
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Terumo Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. W. L. Gore & Associates, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development